Risk of bleeding associated with use of systemic thromboembolic prophylaxis during laparoscopic cholecystectomy
British Journal of Surgery,

Persson G et al. – Thromboprophylaxis in patients undergoing laparoscopic cholecystectomy increased the risk of bleeding, but the occurrence of thromboembolic events was not significantly reduced. Identification of high– and low–risk patients is needed to guide clinical decisions regarding medical thromboprophylaxis.

Methods
  • All cholecystectomies registered in the Swedish Register of Gallstone Surgery and Endoscopic Retrograde Cholangiopancreatography (GallRiks) between 2005 and 2010 were reviewed.
  • Peroperative bleeding was defined as bleeding that could not be controlled by standard surgical techniques, necessitated conversion to an open procedure or required peroperative blood transfusion.
  • Postoperative bleeding was defined as bleeding that necessitated reoperation, transfusion or a prolonged hospital stay.
  • Risk estimates were performed using univariable and multiple logistic regression, and reported as odds ratios (ORs).

Results
  • A total of 51 621 procedures were registered in GallRiks. Some 48 010 patients were included in the analyses, of whom 21 259 (44•3 per cent) received thromboembolic prophylaxis.
  • Peroperative bleeding complications occurred in 400 (1•9 per cent) and postoperative bleeding in 296 (1•4 per cent) given thromboembolic prophylaxis, compared with 189 (0•7 per cent) and 195 (0•7 per cent) respectively without thromboprophylaxis.
  • After adjusting for age, sex, indication for surgery, American Society of Anesthesiologists grade, mode of admission, operative approach, duration of surgery and hospital volume, the OR for peroperative or postoperative bleeding complications in the group receiving prophylaxis was 1•35 (95 per cent confidence interval 1•17 to 1•55).
  • However, in a subgroup analysis the risk was increased in laparoscopic surgery only.
  • At 30–day follow–up, a total of 74 patients (0•2 per cent) had developed postoperative thromboembolism, 43 (0•2 per cent) of those who received thromboembolic prophylaxis compared with 31 (0•1 per cent) of those who did not.

Please login or register to follow this author.
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Gastroenterology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Gastroenterology Articles

1 Fungal microbiota and digestive diseases Alimentary Pharmacology and Therapeutics, March 5, 2014    Review Article

2 Accuracy of rapid fecal calprotectin test in monitoring inflammatory bowel diseases under treatment with TNFα antagonists Digestive Diseases and Sciences, December 9, 2014    Clinical Article

3 Is fecal microbiota transplantation (FMT) an effective treatment for patients with functional gastrointestinal disorders (FGID)? Neurogastroenterology & Motility, December 3, 2014    Review Article

4 Crohn's disease management after intestinal resection: a randomised trial The Lancet, January 7, 2015    Evidence Based Medicine    Clinical Article

5 Low-dose budesonide for maintenance of clinical remission in collagenous colitis: a randomised, placebo-controlled, 12-month trial Gut, January 14, 2015    Clinical Article

6 Effect of a low-flatulogenic diet in patients with flatulence and functional digestive symptoms Neurogastroenterology & Motility, February 25, 2014    Clinical Article
Exclusive Author Commentary

7 Comparing omeprazole with fluoxetine for treatment of patients with heartburn and normal endoscopy who failed once daily proton pump inhibitors: Double-blind placebo-controlled trial Neurogastroenterology & Motility, February 10, 2014    Clinical Article

8 Risk of cancer in patients with inflammatory bowel diseases: A nationwide population-based cohort study with 30 years of follow-up evaluation Clinical Gastroenterology and Hepatology , January 17, 2014    Clinical Article

9 Thiopurines and risk of colorectal neoplasia in patients with inflammatory bowel disease: A meta-analysis Clinical Gastroenterology and Hepatology , September 26, 2014    Evidence Based Medicine

10 Probiotics and antibiotics in IBD Digestive Diseases, January 23, 2015    Clinical Article

11 Association between high dietary intake of the n-3 polyunsaturated fatty acid docosahexaenoic acid and reduced risk of Crohn's disease Alimentary Pharmacology and Therapeutics, February 28, 2014    Clinical Article

12 Long-term outcome of patients with Crohn’s disease who discontinued infliximab therapy upon clinical remission Clinical Gastroenterology and Hepatology , December 5, 2014    Clinical Article

13 Iron treatment and inflammatory bowel disease Journal of Crohn's and Colitis, February 11, 2014    Clinical Article

14 Increased risk of malignancy with adalimumab combination therapy, compared with monotherapy, for Crohn's disease Gastroenterology, April 2, 2014    Clinical Article

15 The dirty side of soap UC San Diego Health System, November 19, 2014

16 Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis Clinical Gastroenterology and Hepatology , September 25, 2014    Clinical Article

17 Diet and inflammatory bowel disease: review of patient-targeted recommendations Clinical Gastroenterology and Hepatology , October 10, 2014    Review Article

18 Use of antibiotics in patients with Crohn's disease: A systematic review and meta-analysis Journal of Digestive Diseases, December 4, 2014    Evidence Based Medicine    Review Article

19 Why, when and how to de-escalate therapy in inflammatory bowel diseases Alimentary Pharmacology and Therapeutics, July 2, 2014    Review Article

20 Fecal lactoferrin in discriminating inflammatory bowel disease from irritable bowel syndrome: A diagnostic meta-analysis Full Text BMC Gastroenterology, July 14, 2014    Free full text    Evidence Based Medicine

Indexed Journals in Gastroenterology: Gastroenterology, American Journal of Gastroenterology, Gutmore

Looking for a physician job? Let us help!

Register now for our free job placement service.
A career consultant will contact you soon.
Click Here for more information.

Get Started Now!

Free-of-charge, no obligation.

Terms and Conditions For M3 Career Consult

By registering with the M3 Career Consult service you authorize M3 USA Corporation to represent you in your job search. The following is a summary of the terms of our service and our mutual obligations to help you find a job:

  • You designate M3 to act as your agent and represent you in your job search;
  • You will not pay us for this service
  • You will advise us of any companies or positions to which you apply or have applied;
  • You will advise us if you believe you are not capable of performing a position for which we submit you, or for which you interview;
  • You will keep all information we provide you about companies or positions strictly confidential;
  • You will promptly provide us with information we request of you;
  • You will make yourself reasonably available for phone, video and in-person conversations and interviews;
  • You will be truthful in all of your communications with us; and
  • You will advise us if anything above changes.
 

The Top Read Articles of 2014 are Now Available

Scouring thousands of peer-reviewed journals and popular press, Our Editors just released the Top Read Articles of the Year. See the Top Read List